Document is current
Any future updates will be listed below
-
Authors
Kotulová, Jana
Baďurová, Klára
Chyra, Zuzana
Ševčíková, Sabina
Garbová, Nikola
Jelínek, Tomáš
Hájek, Roman
Hrdinka, Matouš
-
Funding
Funding for this research was provided by:
LERCO project under Operational Programme Just Transition (CZ.10.03.01/00/22_003/0000003, CZ.10.03.01/00/22_003/0000003, CZ.10.03.01/00/22_003/0000003, CZ.10.03.01/00/22_003/0000003)
Ostravská Univerzita v Ostravě (SGS03/LF/2024, SGS03/LF/2024)
Fakultní nemocnioce Ostrava (MH CZ— DRO— FNOs/2023, MH CZ— DRO— FNOs/2023)
Agentura Pro Zdravotnický Výzkum České Republiky (NU23-03-00374)
OP JAK SALVAGE (CZ.02.01.01/00/22_008/0004644)
- License Information
-
More Information
Article History
Received: 17 February 2025
Accepted: 4 June 2025
First Online: 1 July 2025
Declarations
:
: Not applicable.
: Not applicable.
: Author MH is an employee of Sotio Biotech, which is engaged in the development of antibody-based therapeutics for solid tumors. This employment is not directly related to the content of this manuscript. The authors declare no other potential conflicts of interest.
